Home
Conditions
Carcinoma, Hepatocellular

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 531 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Completed

Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms

NCT01640522

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +32 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery

NCT00410956

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: New York Weill Cornell Cancer Center at Cornell University New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases

NCT04338685

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +13 more
Locations: City of Hope Cancer Center Duarte, California, United States

Rigshospitalet; Onkologisk Klinik København Ø, Denmark

Queen Mary Hospital; Dept of Medicine Hong Kong

Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques

NCT06683820

Conditions: Adenocarcinoma, Amino Acid Metabolism, Inborn Errors, Brain Diseases, +25 more
Locations: 2ndAffiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Completed

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis

NCT03009461

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

NCT04926376

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +18 more
Locations: Auckland District Health Board Grafton, New Zealand

View Trial Details

Completed

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

NCT02143401

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +34 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

UCHealth University of Colorado Hospital Aurora, Colorado, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

NCT03474640

Conditions: Adenocarcinoma, Advanced Malignancies, Carcinoma, +28 more
Locations: Sarcoma Oncology Research Center Santa Monica, California, United States

University of Colorado Denver Aurora, Colorado, United States

University of Miami Hospital Sylvester Comprehensive Cancer Center Miami, Florida, United States

Florida Cancer Specialists Sarasota, Florida, United States

View all 14 locations

View Trial Details

Completed

Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma

NCT03268499

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong

View Trial Details

Completed

Prevention of Recurrent Hepatitis B After Liver Transplantation

NCT00059267

Conditions: Acute Liver Failure, Adenocarcinoma, Blood-Borne Infections, +26 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular trial results

Related conditions